A simple risk score for detecting radiological occult metastasis in patients with resectable or borderline resectable pancreatic ductal adenocarcinoma,Journal of Hepato-Biliary-Pancreatic Sciences

当前位置： X-MOL 学术 › J. Hepato Biliary Pancreat. Sci. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

A simple risk score for detecting radiological occult metastasis in patients with resectable or borderline resectable pancreatic ductal adenocarcinoma
Journal of Hepato-Biliary-Pancreatic Sciences ( IF 3.2 ) Pub Date : 2021-07-27 , DOI: 10.1002/jhbp.1026
Tatsuma Sakaguchi ₁ , Sohei Satoi _{1,

2} , Daisuke Hashimoto ₁ , Tomohisa Yamamoto ₁ , So Yamaki ₁ , Satoshi Hirooka ₁ , Mitsuaki Ishida ₃ , Tsukasa Ikeura ₄ , Kentaro Inoue ₁ , Mitsugu Sekimoto ₁

Affiliation

We advocated carbohydrate antigen (CA) 19-9 ≥ 150 U/mL and tumor size ≥30 mm as “high-risk markers” for predicting unresectability among patients with radiologically resectable (R) or borderline resectable (BR) pancreatic ductal adenocarcinoma (PDAC). The main aim is to establish a risk scoring system for occult abdominal metastasis (OAM) in R/BR PDAC.

中文翻译：

用于检测可切除或临界可切除胰腺导管腺癌患者放射学隐匿转移的简单风险评分

我们提倡将碳水化合物抗原 (CA) 19-9 ≥ 150 U/mL 和肿瘤大小 ≥ 30 mm 作为预测放射可切除 (R) 或临界可切除 (BR) 胰腺导管腺癌 (PDAC) 患者不可切除的“高危标志物” ）。主要目的是建立 R/BR PDAC 中隐匿性腹部转移 (OAM) 的风险评分系统。

更新日期：2021-07-27

点击分享查看原文

点击收藏

阅读更多本刊最新论文本刊介绍/投稿指南11